$2.16
-0.14 (-6.28%)
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)
CAPS Rating:
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
RSS Headlines
Fool UK